Electrophysiological outcomes of radiofrequency ablation for supraventricular tachycardias in patients with congenitally corrected transposition of the great arteries

射频消融治疗先天性矫正型大动脉转位患者室上性心动过速的电生理结果

阅读:1

Abstract

BACKGROUND: Patients with congenitally corrected transposition of the great arteries (cc-TGA) are predisposed to supraventricular tachycardias; however, data regarding the outcomes of catheter ablation (CA) remain limited. OBJECTIVE: This study aimed to assess the clinical impact of CA for supraventricular tachycardias in patients with cc-TGA. METHODS: This retrospective, single-center cohort study evaluated 29 of 112 cc-TGA patients (26%) who underwent CA. Patients were stratified into 3 groups based on surgical history: anatomical repair (n = 10/43, 23%), physiologic repair (n = 14/32, 44%), and no prior surgery (n = 5/37, 14%). Clinical characteristics and procedural outcomes were analyzed. RESULTS: Of the 29 patients who underwent CA, 10 belonged to the anatomical repair group, 14 to the physiologic repair group, and 5 to the non-surgical group. Median age at ablation was significantly lower in the anatomical repair group (25.6 years), compared with physiologic (40.6 years, P = .005) and non-surgical patients (43.8 years, P = .01). The arrhythmia types included intra-atrial reentrant tachycardia (n = 20), focal atrial tachycardia (n = 3), paroxysmal supraventricular tachycardia (n = 2), and atrial fibrillation (n = 6). Cavomitral isthmus ablation was frequently required across all groups. Over a median follow-up of 5.6 years, 3 patients required repeat ablation; all experienced new arrhythmia mechanisms distinct from the index procedure. CONCLUSION: Supraventricular tachycardia patterns varied by surgical background, but cavomitral isthmus ablation was commonly indicated. CA is a key therapeutic strategy in the long-term rhythm management of cc-TGA patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。